Literature DB >> 7615776

Lactobacillus GG vaginal suppositories and vaginitis.

E Hilton, P Rindos, H D Isenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7615776      PMCID： PMC228189          DOI： 10.1128/jcm.33.5.1433-1433.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  13 in total

Review 1.  Extrapulmonary pneumocystosis: the first 50 cases.

Authors:  M C Raviglione
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

2.  Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea.

Authors:  S Siitonen; H Vapaatalo; S Salminen; A Gordin; M Saxelin; R Wikberg; A L Kirkkola
Journal:  Ann Med       Date:  1990-02       Impact factor: 4.709

3.  Fluorogenic substrate detection of viable intracellular and extracellular pathogenic protozoa.

Authors:  P R Jackson; M G Pappas; B D Hansen
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

4.  Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG.

Authors:  S L Gorbach; T W Chang; B Goldin
Journal:  Lancet       Date:  1987-12-26       Impact factor: 79.321

5.  Prevention of travellers' diarrhoea by Lactobacillus GG.

Authors:  P J Oksanen; S Salminen; M Saxelin; P Hämäläinen; A Ihantola-Vormisto; L Muurasniemi-Isoviita; S Nikkari; T Oksanen; I Pörsti; E Salminen
Journal:  Ann Med       Date:  1990-02       Impact factor: 4.709

6.  Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood.

Authors:  G Y Lipschik; V J Gill; J D Lundgren; V A Andrawis; N A Nelson; J O Nielsen; F P Ognibene; J A Kovacs
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

7.  Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis.

Authors:  E Hilton; H D Isenberg; P Alperstein; K France; M T Borenstein
Journal:  Ann Intern Med       Date:  1992-03-01       Impact factor: 25.391

8.  Usefulness of PCR for detection of Pneumocystis carinii DNA.

Authors:  P Roux; I Lavrard; J L Poirot; C Chouaid; M Denis; J L Olivier; M Nigou; M Miltgen
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

9.  Detection of Pneumocystis carinii with DNA amplification.

Authors:  A E Wakefield; F J Pixley; S Banerji; K Sinclair; R F Miller; E R Moxon; J M Hopkin
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

10.  Application of DNA amplification to pneumocystosis: presence of serum Pneumocystis carinii DNA during human and experimentally induced Pneumocystis carinii pneumonia.

Authors:  N Schluger; T Godwin; K Sepkowitz; D Armstrong; E Bernard; M Rifkin; A Cerami; R Bucala
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307
View more
  12 in total

1.  Local Probiotic Therapy for Vaginal Candida albicans Infections.

Authors:  Stefan Miladinov Kovachev; Rossitza Stefanova Vatcheva-Dobrevska
Journal:  Probiotics Antimicrob Proteins       Date:  2015-03       Impact factor: 4.609

2.  Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA.

Authors:  Gillian E Gardiner; Christine Heinemann; Andrew W Bruce; Dee Beuerman; Gregor Reid
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

3.  Her choice: dealing with lactobacilli, vaginitis, and antibiotics.

Authors:  Marie V Pirotta; Suzanne M Garland
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

4.  Enhanced neutralization of HIV by antibodies displayed on the S-layer of Caulobacter crescentus.

Authors:  Mark Duval; Christopher J Lewis; John F Nomellini; Marc S Horwitz; John Smit; Lisa A Cavacini
Journal:  Antimicrob Agents Chemother       Date:  2011-09-06       Impact factor: 5.191

Review 5.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

6.  Antibacterial action of selenium-enriched probiotics against pathogenic Escherichia coli.

Authors:  Jiajun Yang; Kehe Huang; Shunyi Qin; Xianshi Wu; Zhiping Zhao; Fu Chen
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

Review 7.  Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent.

Authors:  Himanshu K Solanki; Dipak D Pawar; Dushyant A Shah; Vipul D Prajapati; Girish K Jani; Akil M Mulla; Prachi M Thakar
Journal:  Biomed Res Int       Date:  2013-08-21       Impact factor: 3.411

8.  Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis.

Authors:  S Nouraei; S Amir Ali Akbari; M Jorjani; H Alavi Majd; M Afrakhteh; A Ghafoorian; H Tafazzoli Harandi
Journal:  ISRN Obstet Gynecol       Date:  2012-10-17

9.  The PAV trial: does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277].

Authors:  Marie Pirotta; Jane Gunn; Patty Chondros; Sonia Grover; Susan Hurley; Suzanne Garland
Journal:  BMC Fam Pract       Date:  2004-03-28       Impact factor: 2.497

10.  Intravaginal lactic Acid bacteria modulated local and systemic immune responses and lowered the incidence of uterine infections in periparturient dairy cows.

Authors:  Qilan Deng; John F Odhiambo; Umar Farooq; Tran Lam; Suzanna M Dunn; Burim N Ametaj
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.